Event Type
Disclosure
Mandatory
Variant
8-K
Results of Operations and Financial Condition. On February 4, 2026, GRI Bio, Inc. (the “Company”) issued a press release reiterating its financial results for t
Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Press Release issued by GRI Bio, Inc., dated February 4, 2026. 104 Cover Page Inter